Lexicon Pharmaceuticals shares owned by UBS Group
Quarter-by-quarter ownership of Lexicon Pharmaceuticals (LXRX) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Lexicon Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Lexicon Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lexicon Pharmaceuticals by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $476k | 353k | 1.35 |
| 2025-06-30 | $379k | 401k | 0.95 |
| 2025-03-31 | $966k | 2.1M | 0.46 |
| 2024-12-31 | $507k | 686k | 0.74 |
| 2024-09-30 | $220k | 140k | 1.57 |
| 2024-06-30 | $271k | 161k | 1.68 |
| 2024-03-31 | $401k | 167k | 2.40 |
| 2023-12-31 | $260k | 170k | 1.53 |
| 2023-09-30 | $137k | 125k | 1.09 |
| 2023-06-30 | $222k | 98k | 2.27 |
| 2023-03-31 | $337k | 139k | 2.43 |
| 2022-12-31 | $305k | 160k | 1.91 |
| 2022-09-30 | $225k | 94k | 2.40 |
| 2022-06-30 | $396k | 212k | 1.87 |
| 2022-03-31 | $445k | 212k | 2.10 |
| 2021-12-31 | $379k | 96k | 3.94 |
| 2021-09-30 | $19k | 4.0k | 4.65 |
| 2021-06-30 | $9.0k | 2.0k | 4.52 |
| 2021-03-31 | $80k | 14k | 5.84 |
| 2020-12-31 | $45k | 14k | 3.32 |
| 2020-09-30 | $4.0k | 2.9k | 1.37 |
| 2020-06-30 | $55k | 27k | 2.03 |
| 2020-03-31 | $32k | 17k | 1.93 |
| 2019-12-31 | $199k | 48k | 4.10 |
| 2019-09-30 | $73k | 24k | 3.03 |
| 2019-06-30 | $49k | 7.6k | 6.38 |
| 2019-03-31 | $29k | 5.2k | 5.55 |
| 2018-12-31 | $1.2M | 178k | 6.56 |
| 2018-09-30 | $1.8M | 163k | 10.75 |
| 2018-06-30 | $1.5M | 123k | 12.03 |
| 2018-03-31 | $1.9M | 219k | 8.57 |
| 2017-12-31 | $1.1M | 113k | 9.88 |
| 2017-09-30 | $1.9M | 159k | 12.29 |
| 2017-06-30 | $2.2M | 133k | 16.45 |
| 2017-03-31 | $1.9M | 131k | 14.34 |
| 2016-12-31 | $1.7M | 120k | 13.83 |
| 2016-09-30 | $629k | 35k | 18.08 |
| 2016-06-30 | $790k | 56k | 14.12 |
| 2016-03-31 | $615k | 52k | 11.76 |
| 2015-12-31 | $1.9M | 144k | 13.31 |
| 2015-09-30 | $235k | 22k | 10.70 |